ACLS Provider: Course

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. Synchronized cardioversion at 100 J is effective for restoring a stable rhythm in unstable ventricular tachycardia.

Incorrect. PETCO2 values greater than 10 mmHg during CPR indicate adequate chest compressions and blood circulation.

Incorrect. For unstable narrow, irregular tachycardias, synchronized cardioversion at 120-200 J is recommended.

Incorrect. Oxygen levels should be monitored and optimized to maintain saturation within the target range of 92-96%.

Incorrect. Immediate defibrillation is the most effective intervention for a witnessed cardiac arrest in VF.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Defibrillation is the primary treatment for pulseless VT, aiming to restore organized cardiac activity.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Atrial flutter presents as a sawtooth pattern on the ECG and requires rate control or cardioversion depending on stability.

Incorrect. The jaw-thrust avoids neck movement, making it the preferred airway technique for patients with suspected cervical spine injuries.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. The same compression rate as adults ensures adequate perfusion in pediatric patients during CPR.

Incorrect. Shouting for help ensures additional resources and a defibrillator are quickly available.

Incorrect. Magnesium sulfate is used to treat torsades de pointes but is not the first-line drug for VF, where epinephrine is prioritized.

Incorrect. Optimal for maintaining adequate circulation without risking poor perfusion due to excessive speed.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and terminate torsades de pointes.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. A single rescuer performs 30 compressions followed by 2 breaths to maximize perfusion and oxygenation in pediatric CPR.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.

Incorrect. Adenosine is the first-line drug for stable SVT, while synchronized cardioversion is used for unstable SVT.

Incorrect. PEA is treated with CPR, epinephrine, and identifying reversible causes to restore organized electrical activity.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Waveform capnography provides real-time confirmation of ET tube placement and ensures proper ventilation.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. Defibrillation attempts should be separated by 2-minute CPR cycles to ensure effective perfusion and rhythm evaluation.

Incorrect. Epinephrine is given as a continuous infusion to maintain adequate heart rate and perfusion when atropine is ineffective.

Incorrect. Naloxone blocks opioid receptors and is administered to reverse opioid overdose and restore adequate respiration.

Incorrect. Post-ROSC care focuses on stabilizing ventilation and oxygenation to prevent hypoxia or hyperoxia.

Incorrect. VF is a shockable rhythm, and defibrillation is the primary treatment to restore an organized rhythm.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation without risking incomplete recoil or excessive fatigue.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. The recommended rate for chest compressions is 100-120 compressions per minute to maximize perfusion.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. PETCO2 >10 mmHg during CPR indicates effective chest compressions generating sufficient circulation.

Incorrect. Maximum energy for monophasic defibrillators; for biphasic, follow manufacturer recommendations.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore an organized rhythm.

Incorrect. Magnesium sulfate is the first-line treatment for torsades de pointes as it stabilizes the myocardium.

Incorrect. Adult defibrillation with a biphasic defibrillator typically starts at 120-200 J, not 360 J, depending on the manufacturer's guidelines.

Incorrect. Switching compressors every 2 minutes reduces rescuer fatigue, ensuring high-quality chest compressions are maintained.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. Pausing compressions for more than 10 seconds interrupts perfusion and reduces the chances of ROSC.

Incorrect. Maintaining oxygen saturation at 92-96% avoids hypoxia while preventing hyperoxia, which can cause further tissue damage.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. Reduces the risk of oxidative stress and worsened outcomes by preventing hyperoxia.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. Epinephrine is repeated every 3-5 minutes during cardiac arrest to enhance perfusion pressure.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. Pediatric defibrillation begins at 2 J/kg and increases to 4 J/kg for subsequent shocks if needed.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized electrical activity.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the first-line treatment for torsades de pointes.

Incorrect. Providing 6-8 breaths per minute prevents hyperventilation and maintains adequate oxygenation during CPR with an advanced airway.

Incorrect. The correct initial dose of amiodarone for pulseless VT is 300 mg IV/IO, followed by 150 mg for a second dose if needed.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. Synchronized cardioversion with 120-200 J is used to restore normal rhythm in unstable atrial fibrillation.

Incorrect. Compressing 2-2.4 inches ensures effective perfusion during adult CPR while minimizing the risk of injury.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. PETCO2 levels greater than 10 mmHg suggest that chest compressions are generating adequate circulation.